Oocytes are held in meiotic prophase for prolonged periods until hormonal signals trigger meiotic divisions. Key players of M-phase entry are the opposing Cdk1 kinase and PP2A-B55δ phosphatase. In Xenopus, the protein Arpp19, phosphorylated at serine 67 by Greatwall, plays an essential role in inhibiting PP2A-B55δ, promoting Cdk1 activation.
INTRODUCTION
In vertebrates, oocyte meiotic divisions are controlled by the cAMP-dependent protein kinase A, PKA. The activity of PKA is responsible for arresting fully-grown oocytes in prophase of the first meiotic division for long-lasting periods in order to allow cell growth and nutrient accumulation required for fertilization and the early embryogenesis 1, 2 . The posttranscriptional mechanisms controlled by PKA in oocytes were largely unknown until the identification of the protein Arpp19 as its long sought substrate in Xenopus 3 . In this species, Arpp19 phosphorylation at S109 by PKA is critical to maintain oocytes arrested in prophase.
Release from the prophase block is promoted by progesterone, which triggers within 0.5h a drop in the cAMP concentration and the down-regulation of PKA activity. As a result, Arpp19 is dephosphorylated at S109 and unlocks a signaling pathway that leads within 3 to 5h to the activation of the Cdk1-Cyclin B complex, or MPF (M-phase promoting factor), the universal inducer of eukaryotic cell division. Once activated, Cdk1-Cyclin B complexes trigger the resumption of the first meiotic cell division which starts with nuclear envelope breakdown, termed germinal vesicle breakdown (GVBD) in oocytes 4 .
The biochemical steps linking PKA downregulation and Arpp19 dephosphorylation at S109 to Cdk1-Cyclin B activation involve the translation of two proteins, Cyclin B and the kinase Mos 5 . Newly synthesized Cyclin B associates with free Cdk1 while Mos indirectly activates MAPK (mitogen-activated protein kinase). Both events allow the formation of newly active Cdk1-Cyclin B complexes and the hyperphosphorylation of the two opposed regulators of Cdk1, the phosphatase Cdc25 and the kinase Myt1 4 . Upon phosphorylation, Cdc25 activates Cdk1 by dephosphorylating T14 and Y15, whereas its antagonistic enzyme, Myt1, is concomitantly inhibited 6 . Importantly, Cdk1 activation also requires the inhibition of a specific phosphatase, the PP2A-B55δ isoform, which counteracts Cdk1-dependent phosphorylations of mitotic/meiotic substrates, including Cdc25 and Myt1 7 . PP2A-B55δ inhibition is achieved by Arpp19, a specific inhibitor of this phosphatase when phosphorylated at S67 by the kinase Greatwall (Gwl) 8, 9 . Hence, Arpp19 is a central player of meiosis resumption through two distinct functions at two different periods. In prophase oocytes, Arpp19 is phosphorylated by PKA at S109 and holds the prophase block. Upon hormonal stimulation, its dephosphorylation at S109 occurs within 1h and unlocks a signaling pathway leading to meiotic division. At the very end of this molecular pathway, 3 to 5h later, Arpp19 is phosphorylated at S67 by Gwl and inactivates PP2A-B55δ, hence promoting Cdk1-Cyclin B activation 4 .
The molecular regulation of this last step, involving Gwl, Arpp19 and PP2A, has been well deciphered in mitosis and meiosis. PP2A is a major S/T protein phosphatase conserved across eukaryotes. It acts as a heterotrimeric complex composed of a catalytic C subunit, a scaffolding A subunit, and a variable B subunit which regulates PP2A intracellular localization and substrate specificity 10 . Eukaryotes have four B-subunit families known as B (B55), B' (B56), B'' (PR72) and B''' (striatin), each of them comprising several very close isoforms whose number differs according the species 11 . from yeast to humans, Gwl kinase displays conserved functions in mitosis 12 which are mediated by the phosphorylation of its sole substrate identified so far, Arpp19, and its paralog, α-endosulfine (ENSA). ENSA and Arpp19 derive from the duplication of an ancestral gene that evolved through new duplications and losses (http://www.ensembl.org; http://www.treefam.org), providing from one to four homologues in the different species 13, 14 . Both Arpp19 and ENSA share highly conserved sequence identity/similarity across most eukaryotes. Their most conserved region is centered around the FDS 67 GDY motif (X. laevis numbering). Within this motif, S67 is phosphorylated by Gwl to the same extent in Arpp19 and ENSA, generating phosphorylated proteins that bind to and equally inhibit the specific PP2A-B55δ isoform by titrating the phosphatase away from all other substrates and making themselves its preferential substrates 15, 16 . Whether Arpp19 and ENSA display specific functions is not clear, although some evidence shows that, unlike ENSA, Arpp19 plays an essential role during mouse embryogenesis and in regulating mitotic and meiotic divisions 17 . In Xenopus oocyte, it is clearly established that S67 phosphorylation of Arpp19 by Gwl promotes its binding to PP2A-B55δ and the inhibition of the phosphatase 18, 19 . Released from the activity of its opposite enzyme, Cdk1 phosphorylates its two antagonistic regulators, Cdc25 and Myt1, setting up the positive feedback loop responsible for its abrupt and full activation 4 . Importantly, the Gwl/Arpp19/PP2A-B55δ module is under the control of Cdk1, being included inside the autoactivation loop. Hence, the antagonistic relationship between Arpp19-Gwl and PP2A-B55δ greatly contributes to the abruptness and irreversibility of cell division entry 20 .
PKA phosphorylates ENSA and Arpp19 at a consensus RKP/SS 109 LV motif (X. laevis numbering) conserved among most animals. Specific functions have been attributed to the PKA-phosphorylated form of Arpp19/ENSA, notably in striatal neurons upon dopaminergic stimulation 21 . No specific role related to cell division had been described until we discovered that Arpp19 phosphorylation by PKA is essential to arrest Xenopus oocytes in prophase 3 .
The S109 phosphorylation by PKA does not impede the phosphorylation at S67 by Gwl nor its ability to inhibit PP2A-B55δ when phosphorylated at S67 22 . Moreover, Arpp19 is rephosphorylated at S109 by an unknown kinase distinct from PKA, concomitantly with its S67 phosphorylation by Gwl, at time of Cdk1 activation 3 . Thus, the critical events controlled by the S109 phosphorylation of Arpp19 that maintain the prophase block in oocytes remain an open question. Another issue to unravel the prophase release regards the identity of the phosphatase that dephosphorylates Arpp19 at S109 at the onset of meiosis resumption.
Since this event is important to unlock the transduction pathway leading to cell division, this unidentified phosphatase is a critical player of oocyte meiotic division.
Here, we identify PP2A-B55δ as the phosphatase that dephosphorylates Arpp19 at S109, thus enabling oocytes to resume meiosis. The level of Arpp19 phosphorylated at S109 in prophase-arrested oocytes results from a balance between PKA and PP2A-B55δ activities in favor of the kinase. Upon hormonal stimulation, PP2A-B55δ activity remains unchanged while PKA is downregulated, leading to the partial dephosphorylation of Arpp19 at S109 that unlocks the prophase arrest. Therefore, the timing of meiosis resumption relies on the temporal coordination of S109 and S67 phosphorylations of Arpp19, orchestrated by one single phosphatase, PP2A-B55δ, opposing two kinases, PKA and Gwl.
RESULTS

Active dephosphorylation at Arpp19 S109 opposed by PKA in prophase oocytes
The S109 residue of Arpp19 phosphorylated by PKA in prophase oocytes is dephosphorylated in response to progesterone by an unknown phosphatase 3 , termed S109phosphatase until its identification. The level of S109-phosphorylated Arpp19 in prophasearrested oocytes could result from either the sole activity of PKA or a balance between PKA and S109-phosphatase in favor of PKA. To address this, we first assayed S109-phosphatase activity in extracts from prophase oocytes. As a substrate, we used GST-tagged Arpp19 previously in vitro phosphorylated at S109 by PKA (pS109-GST-Arpp19) 22 . This protein was coupled to GSH-beads and then incubated in prophase extracts. S109 phosphorylation of pS109-GST-Arpp19 recovered from extracts was monitored by western blot using a specific phospho-S109-Arpp19 antibody 3 . In the absence of ATP, Arpp19 was efficiently dephosphorylated at S109 ( Fig. 1A) , showing that S109-phosphatase is active in prophase extracts. Adding ATP reduced Arpp19 dephosphorylation at S109 ( Fig. 1A ). When the specific inhibitor of PKA, PKI 23 , was added to extracts in the presence of ATP, pS109-GST-Arpp19 was efficiently dephosphorylated (Fig. 1A ). This indicates that S109-phosphatase activity is counterbalanced by PKA in prophase extracts. Furthermore, a non-phosphorylated form of GST-Arpp19 showed phosphorylation on S109 in extracts that was dependent on ATP and sensitive to PKI (Fig. 1B) . These results demonstrate that PKA and S109phosphatase are both active and regulate Arpp19 phosphorylation at S109 in prophase extracts, with PKA dominating. In subsequent experiments, PKI was included in order to block PKA activity to facilitate analysis of its opposing phosphatase.
We next determined that S109-phosphatase belongs to the group of okadaic acid (OA)sensitive phosphatases, which includes PP1, PP2A and phosphatases related to PP2A 11, 24 .
Prophase extracts were supplemented with 1 or 10 µM OA and then with PKI and the S109 phosphatase substrate, pS109-GST-Arpp19. Both OA concentrations prevented Arpp19 dephosphorylation at S109 (Fig. 1C ).
We ascertained whether Arpp19 phosphorylation at S109 is also subject to a turnover in intact oocytes. We used as S109-phosphatase substrate a GST-truncated form of Arpp19, corresponding to its C-terminal part (68-117) (Cter-GST-Arpp19). This peptide contains S109 but lacks S67 that is phosphorylated by Gwl during meiosis resumption 19 . In vitro, Cter-GST-Arpp19 was efficiently phosphorylated at S109 by PKA and efficiently dephosphorylated at S109 when incubated in prophase extracts with PKI ( Supplementary Fig. 1A-B ). Moreover, unlike full-length Arpp19 protein 3, 19 , Cter-GST-Arpp19 did not interfere with meiotic maturation ( Supplementary Fig. 1C -D). Prophase oocytes were injected with Cter-GST-Arpp19 and either stimulated with progesterone or injected with PKI or OA. Cter-GST-Arpp19 was then isolated by pull-down at various times before Cdk1 activation. As shown in Fig. 1D , Cter-GST-Arpp19 was in vivo phosphorylated at S109 in prophase oocytes and was partly dephosphorylated in response to progesterone, thus reproducing the dephosphorylation of endogenous Arpp19 observed upon hormonal stimulation 3 . In the absence of progesterone, PKI injection induced the full dephosphorylation of Cter-GST-Arpp19 at S109 while OA injection increased the S109 phosphorylation level (Fig. 1D ). Hence, S109-phosphatase is an OA-sensitive phosphatase that is active and dephosphorylates Arpp19 at S109 in prophase oocytes. In extracts and intact oocytes, Arpp19 phosphorylation at S109 results from a balance between PKA and its opposing phosphatase, in favor of PKA.
S109-phosphatase is distinct from PP1 and PP5
As the S109-phosphatase is inhibited by OA, we analyzed which ones of the known OAsensitive phosphatases are expressed in Xenopus oocytes. Western blots revealed that the catalytic subunits of PP1, PP4, PP5, PP6 and PP2A (PP2A-C) as well as PP2A structural (PP2A-A) and regulatory (B55δ and B56ε) subunits are expressed at the same level in prophase-and metaphase II-arrested oocytes ( Fig. 2A ). In an attempt to identify which one corresponds to S109-phosphatase, prophase extracts were fractionated by precipitation using increasing amounts of ammonium sulfate. S109-phosphatase and PKA activities were then assayed, using as substrates pS109-GST-Arpp19 and GST-Arpp19 respectively. S109phosphatase activity was recovered in the 40% precipitate ( Fig. 2B ) whereas PKA activity was precipitated by 60% ammonium sulfate ( Fig. 2C ). S109-phosphatase activity did no longer depend on PKI in the 40% precipitate ( Fig. 2B ), in agreement with the absence of PKA activity in this precipitate ( Fig. 2C ).
Each precipitated fraction was further analyzed by western blot with antibodies against OAsensitive phosphatases, PKA and PKI. Consistently with the S109 phosphorylation activity measured in Fig. 2C , PKA was recovered in the 60% ammonium sulfate precipitate ( Fig. 2D ).
PP2A, PP4 and PP6, as well as the scaffold PP2A-A subunit, were recovered in the 40% precipitate ( Fig. 2D ). In contrast, PP1 and PP5 were mostly detected in the 60% precipitate ( Fig. 2D ). Hence, the ammonium sulfate fractionation supports our previous results showing that S109-phosphatase is counterbalanced by PKA and indicates that it corresponds neither to PP1 nor to PP5.
Biochemical identification of S109-phosphatase as PP2A-B55α/δ
To identify the S109-phosphatase, a chromatography-based procedure was undertaken.
PKI-supplemented prophase extracts were ultracentrifuged and the supernatant was fractionated by four successive steps of chromatography: two anion exchange columns, Uno Q and Mono Q, an hydrophobic column, Phenyl-Superose, and a size-exclusion column, Superose 12 ( Supplementary Fig. 2 ). At each step, S109-phosphatase activity was assayed in the fractions using pS109-GST-Arpp19 as a substrate. Fractions were western blotted with various antibodies against phosphatases and some were subject to LC-MS/MS experiments.
Following the Uno Q column, S109-phosphatase activity was recovered in the flow-through ( Fig. 3A) , as well as PP2A-B55δ, PP2A-B56ε and the catalytic subunits of PP1, PP4, PP5 and PP6 (Fig. 3A) . Fractions 2 to 5 in the flow-through were pooled and loaded on a Mono Q column. S109-phosphatase activity was predominantly eluted in fractions 5 to 8 (Fig. 3B ).
Fractions 5 and 6 contain PP2A-B55δ, whereas PP4, PP5 and PP6 were not detectable in these fractions ( Fig. 3B , Table 1 ). Some PP1 was present in fraction 6 but not in fraction 5 ( Fig. 3B , Table 1 ). S109-phosphatase activity was also detected in fractions 7 and 8 that contain various amounts of PP1, PP2A-B55δ, PP2A-B56ε, PP4, PP5, PP6 and PP2C ( Fig.   3B and Table 1 ). Hence, PP2A-B55δ is predominant in fractions 5 and 6 whereas fractions 7 and 8 are enriched in PP1, PP2A-B56ε, PP4, PP5, PP6 and PP2C, with few PP2A-B55δ.
Fraction 6 corresponds to an intermediary between both groups. The procedure to isolate S109-phosphatase was pursued by separately analyzing fraction 5, fraction 6 and a pool of fractions 7 and 8 ( Supplementary Fig. 2B ).
Fractions 5 and 6 were subjected to Phenyl-Superose chromatography. For both fractions, S109-phosphatase activity was eluted in a single fraction, fraction 11, where the main phosphatase present is PP2A-B55α/δ with traces of PP4 ( Fig. 4A , Supplementary Fig. 3A and Table 1 ). Consistently with the absence of PP1, PP5 and PP6 in the input, these three phosphatases were undetectable in fraction 11 by LC-MS/MS analysis. PP1, initially present in fraction 6 of the Mono Q, was not recovered in any fraction from 7 to 16 of the Phenyl-Superose column (Table 1) . Therefore, PP2A-B55α/δ is the major phosphatase present in the fraction 11 that contains S109-phosphatase activity. This fraction was then loaded on a Superose 12 column. The maximal activity of S109-phosphatase was recovered in fractions 8 and 9 where the only phosphatase present was PP2A-B55α/δ ( Fig. 4B , Supplementary Fig.   3B and Table 1 ).
Fractions 7 and 8 from the Mono Q column were pooled and subject to Phenyl-Superose chromatography. S109-phosphatase activity was eluted in fractions 10 to 12 ( Fig. 5A ). PP2A-B55δ, PP2A-B56α/β/ε and PP2C were recovered in these fractions while PP1, PP4, PP5 and PP6 were not detected or were present in trace amounts ( Fig. 5A and Table 1 ). Fractions 10 and 11 were pooled and loaded on a gel filtration Superose 12 column. S109-phosphatase activity was recovered in fractions 7 to 13, with a peak in fractions 10 and 11 (Fig. 5B ). The phosphatases contained in these fractions were PP2A-B55δ, PP2A-B56α/β/ε and PP2C ( Fig.   5B and Table 1 ).
Hence, the biochemical procedure to isolate S109-phosphatase activity led to PP2A-A/C and excluded PP1, PP4, PP5 and PP6. As PP2C is insensitive to OA 25 , this phosphatase is unlikely responsible for S109-phosphatase activity. Remarkably, S109-phosphatase activity was carried by PP2A-A/C associated with either B55α/δ or B56α/β/ε. The biochemical isolation procedure was performed 4 times with LC-MS/MS analysis performed on 3 of these 4 experiments. Experiment 1 was presented in Figs. 3-5, Supplementary Fig. 3 and Table 1, while Supplementary Table 1 summarizes the two other experiments. In experiment 2, fractions 5 to 8 from the Mono Q column were pooled before Phenyl-Superose. In experiment 3, S109-phosphatase was eluted in a single fraction from the Mono Q column.
The final fractions from the Superose 12 column containing S109-phosphatase activity were analyzed by LC-MS/MS analysis (Supplementary Table 1 ). PP2A-B56 isoform was recovered in the final fractions of experiment 2, in which fractions 5 to 8 from the Mono Q column were pooled, whereas it was barely detectable in experiment 3 where S109phosphatase was found in a single fraction after the Mono Q column. This argues for B56 contaminating S109-phosphatase fractions when the Mono Q fractions are pooled. In contrast, PP2A-B55 isoforms were recovered in all experiments ( Supplementary Table 1 ), arguing for PP2A-B55α/δ being the main phosphatase carrying S109-phosphatase activity.
PP2A-B55δ dephosphorylates Arpp19 at S109 in prophase extracts
If PP2A-B55δ corresponds to the S109-phosphatase, it should be active in prophasearrested oocytes. PP2A-B55δ is known to dephosphorylate Arpp19 at S67 16 . To assay its activity in prophase extracts, we used Arpp19 phosphorylated at both S67 and S109 (pS67-pS109-GST-Arpp19). This substrate allows monitoring the concomitant dephosphorylation of S109 and S67, respectively catalyzed by S109-phosphatase and PP2A-B55δ. As expected, S109-phosphatase dephosphorylated pS67-pS109-GST-Arpp19 at S109 in a PKI-and OAdependent manner ( Fig. 6A ). Interestingly, pS67-pS109-GST-Arpp19 was also dephosphorylated at S67 by PP2A-B55δ in extracts ( Fig. 6B ). This event was prevented by OA but insensitive to PKI ( Fig. 6B ), an expected result as S67 is targeted by Gwl but not by PKA 19 . This result indicates that PP2A-B55δ is active in prophase oocytes and not affected by PKA.
To ascertain that PP2A-B55δ is responsible for Arpp19 dephosphorylation at S109, this phosphatase was specifically depleted from prophase extracts using its specific inhibitor, S67-phosphorylated Arpp19, coupled to GSH beads. To avoid S67 dephosphorylation, GST-Arpp19 was thiophosphorylated with ATP-γS (tpS67-GST-Arpp19) 19 . As a positive control, microcystin-beads known to inhibit all PP2A-A/C isoforms were used 26 . After incubation with either tpS67-GST-Arpp19-beads or microcystin-beads, supernatants and beads were separated. As expected from the pan-specificity of microcystin, nearly all PP2A subunits were depleted from the supernatant and recovered on the microcystin-beads ( Fig. 6C ). Given the specificity of tpS67-GST-Arpp19 towards PP2A-B55δ isoform, B55δ was almost fully depleted after incubation with tpS67-GST-Arpp19-beads, whereas some PP2A-A/C subunits were still detected ( Fig. 6C ). S109-phosphatase activity was then assayed in the supernatants. In the absence of PKI, Arpp19 phosphorylation at S109 was increased in PP2A-depleted supernatants with either microcystin-or tpS67-GST-Arpp19-beads ( Fig. 6D) ,
showing that PKA actively phosphorylates Arpp19 at S109 in the absence of PP2A. Inhibiting PKA with PKI led to a strong S109 dephosphorylation of Arpp19 in prophase extracts (Fig.   6D ). In contrast, such a dephosphorylation was no longer observed in the microcystindepleted supernatants and was strongly reduced in the supernatants depleted for PP2A-B55δ using tpS67-GST-Arpp19 ( Fig. 6D ). Altogether, these results indicate that PP2A-B55δ behaves as the S109-phosphatase in prophase extracts: it is active in dephosphorylating Arpp19 and counterbalanced by PKA.
PP2A-B55δ dephosphorylates Arpp19 at S109 in intact oocytes
Whether PP2A-B55δ also dephosphorylates Arpp19 at S109 in intact oocytes was ascertained using its specific inhibitor, tpS67-GST-Arpp19. To avoid any side-specific effect due to S109 phosphorylation, a non-phosphorylatable Arpp19 mutant, in which S109 was replaced by alanine, was used (S109A-tpS67-GST-Arpp19) 22 . S109A-tpS67-GST-Arpp19 was injected in prophase oocytes. As expected 7, 19, 27 , this protein promoted meiosis resumption and accelerated the process induced by progesterone ( Fig. 7A ). Cdk1 activation was ascertained by western blotting phosphorylated MAPK (Fig. 7B ), a marker of Cdk1 activation 28 . Arpp19 dephosphorylation at S109 was analyzed by western blot (Fig. 7B ). As previously shown 3 , the protein was partially dephosphorylated at S109 within 1h after progesterone addition and was then rephosphorylated at this residue before GVBD in control oocytes ( Fig. 7B ). In contrast, Arpp19 was not dephosphorylated at S109 when PP2A-B55δ was specifically inhibited by S109A-tpS67-GST-Arpp19 ( Fig. 7B ). Hence, inhibiting PP2A-B55δ in oocytes is sufficient to abolish Arpp19 dephosphorylation at S109 induced by progesterone. PP2A-B55δ is therefore responsible for Arpp19 dephosphorylation during oocyte meiosis resumption. Arpp19 phosphorylation at S109 is even increased upon PP2A-B55δ inactivation (Fig. 7B ). Hence, Arpp19 is not fully phosphorylated in prophase oocytes and can be over-phosphorylated by PKA when its opposing phosphatase, PP2A-B55δ, is inhibited.
Arpp19 dephosphorylation at S109 by PP2A-B55δ is independent of Cdk1
Cdk1 activation depends on PP2A-B55δ inhibition thanks to Arpp19 phosphorylation at S67 that occurs at GVBD 19 . This negative action of PP2A-B55δ is controlled by Cdk1 itself, which indirectly activates Gwl, constituting a positive feedback loop 4 . Remarkably, our present results reveal that PP2A-B55δ also positively regulates meiosis resumption by dephosphorylating Arpp19 at S109 upstream Cdk1 activation, as early as 1h after progesterone stimulation 3 . Hence, both steps, critical for Cdk1 activation, involve PP2A-B55δ and Arpp19 but occur sequentially over time. To ensure that the early action of PP2A-B55δ is disconnected from its late function, we investigated whether Arpp19 dephosphorylation at S109 is independent of Cdk1 activity. Prophase oocytes were injected with a specific inhibitor of Cdk1 29 , the protein p21 Cip1 and were then stimulated with progesterone. In control oocytes, Arpp19 was phosphorylated at S109 in prophase, partially dephosphorylated at S109 within 1h after progesterone addition and then rephosphorylated at this residue just before GVBD ( Fig. 8A ). P21 Cip1 injection efficiently prevented Cdk1 activation in response to progesterone ( Fig. 8A ). Under these conditions, Arpp19 was still dephosphorylated at S109 in response to progesterone and was then maintained in its partially dephosphorylated state ( Fig. 8A ). This result indicates that PP2A-B55δ actively dephosphorylates Arpp19 at S109 well before and independently of Cdk1 activation. Both actions of PP2A-B55δ are therefore temporally and functionally disconnected in the oocyte.
PP2A-B55δ activity is not regulated in the early stages of meiosis resumption
In prophase oocytes, Arpp19 phosphorylation at S109 depends on a balance between PKA and PP2A-B55δ in favor of PKA. Arpp19 dephosphorylation could be either promoted by the sole inhibition of PKA or by the concomitant up-regulation of PP2A-B55δ activity. To address this issue, we assayed PP2A-B55δ activity in extracts from oocytes either in prophase or collected 1h after progesterone stimulation. As expected, endogenous Arpp19 was partially dephosphorylated at S109 (Fig. 8B ). PP2A-B55δ substrate, pS109-GST-Arpp19, was added to oocyte lysates in the presence or in the absence of OA, and its dephosphorylation was ascertained as a function of time. As shown in Fig. 8C -D, Arpp19 was dephosphorylated in an OA-dependent manner, at a similar rate in extracts from oocytes in prophase or stimulated by progesterone. The experiment was performed 7 times using different females ( Fig. 8E ). No statistical difference was observed regarding the specific activity of PP2A-B55δ at both stages. Therefore, PP2A-B55δ activity is not up-regulated by progesterone at the early stages of meiosis resumption and Arpp19 dephosphorylation at S109 solely depends on PKA downregulation.
DISCUSSION
In all vertebrates, a high level of PKA activity arrests oocytes in prophase of the first meiotic division for long periods. In Xenopus, Arpp19 phosphorylated at S109 by PKA plays an important part in maintaining the prophase block 3 . Progesterone releases this block by decreasing cAMP levels and PKA activity within 1h, resulting in a partial dephosphorylation of Arpp19 at S109 sufficient to trigger a signaling pathway that leads, 3 to 5h later, to Cdk1 activation 3,30-32 . We have now uncovered the phosphatase responsible for Arpp19 dephosphorylation at S109, unexpectedly finding it to be the same PP2A isoform that opposes Cdk1 during M-phase entry.
PP1 was initially an attractive candidate to oppose the action of PKA during oocyte prophase arrest. PKA and PP1 antagonistically regulate the activity of many physiological effectors involved in cell cycle regulation. In particular, PP1 inhibition blocks progesterone and PKIinduced meiotic maturation in Xenopus oocytes. PP1 was thus proposed to dephosphorylate a PKA substrate, still unknown at that time 33 . PP1 also positively regulates mitosis by contributing to Cdc25C activation and by controlling structural events such as centrosome splitting, spindle assembly and microtubules-kinetochores attachment 34 . PP1 activity is then repressed at mid-mitosis by Cdk1 phosphorylation and reactivated at the end of mitosis where it contributes to the dephosphorylation of Cdk1 substrates [34] [35] [36] . Nevertheless, we have ruled out the possibility that PP1 is responsible for Arpp19 dephosphorylation on S109. PP1 did not associate with S109-phosphatase activity in the ammonium sulfate precipitates nor after the Mono Q column.
All our in vitro or in vivo approaches demonstrate that the phosphatase that acts on Arpp19 at S109 is a PP2A isoform. We were further able to determine that this activity is predominantly carried by the B55 subunit, i.e. the same isoform that participates as an essential component of the M-phase switch. We detected B55, in some cases accompanied by B56, in the active S109-phosphatase fractions obtained from all three biochemical isolation procedures analyzed by western blot and LC-MS/MS, as well as in an initial isolation experiment monitored by western blot only. While PP2A-B55 is thus clearly the main phosphatase responsible for S109 dephosphorylation of Arpp19, PP2A-B56 can also potentially contribute, at least in extracts. A contribution of PP2A-B56 to Arpp19 S109 dephosphorylation in oocyte extracts could explain why the pan-isoform PP2A inhibitor microcystin blocks this activity more effectively than specific inhibition of PP2A-B55δ using S67-phosphorylated Arpp19. In strong contrast with these results in extracts, inhibiting PP2A-B55δ using S67-phosphorylated Arpp19 in intact oocytes fully abolishes S109 dephosphorylation of endogenous Arpp19 induced by progesterone and even increases its phosphorylation level. These experiments unequivocally establish that in vivo, PP2A-B55 is the physiological phosphatase that dephosphorylates Arpp19 at S109. The minor contribution of PP2A-B56 in oocyte extracts could result from its release from discrete subcellular compartments during extract preparation. It has been established that PP2A-B56 localizes specifically to kinetochores and centromeres, participating in chromatid-microtubule interactions and silencing of the spindle assembly checkpoint 37, 38 . Likely relating to this Mphase role, PP2A-B56 is involved in the metaphase II-arrest of Xenopus oocyte by regulating the APC/C inhibitor, XErp1 39, 40 . These M-phase roles of PP2A-B56 are not directly connected to Cdk1 regulation and do not involve Arpp19. Accordingly, Arpp19 lacks the two known binding motifs for PP2A-B56 but includes bipartite recognition determinants for PP2A-B55 [41] [42] [43] .
Each of the four B subfamilies comprises several isoforms with very closely related sequences, no discernible differences in their substrate binding pockets and substantial substrate specificity overlap 44 . In the present study, our biochemical isolation procedures identify B55δ as being associated with PP2A-A/C that dephosphorylates Arpp19 at S109.
B55α was also detected by LC-MS/MS experiment. Since we have no specific anti-B55α antibody, we cannot exclude that S109-phosphatase activity is a mixture of PP2A-B55α and PP2A-B55δ. Nevertheless, in Xenopus oocytes, B55δ accounts for 70% or more of the total B55 subunits, with B55α and B55β antibodies failing to detect endogenous proteins, due to their low expression level 7, 45 . Moreover, Arpp19 is not detected within the protein interactome of PP2A-B55α 46 . We therefore ascribe the majority of the phosphatase responsible for dephosphorylating Arpp19 at S109 to the PP2A subset containing the B55δ subunit.
Similarly, in Xenopus egg extracts, PP2A-B55δ is the key phosphatase isoform that acts on Cdk1 substrates and is inhibited by Arpp19 phosphorylated at S67, a property not shared by the three other Xenopus PP2A-B55 holoenzymes 7, 8, 45 .
Our results revealed that Arpp19 phosphorylation at S109 is subject to dynamic turnover in prophase-arrested oocytes. The two mutually antagonistic enzymes, PKA and PP2A-B55δ, work simultaneously, with the action of PP2A-B55δ being swamped by PKA. This contrasts with other systems in which PKA plays a critical role in phosphate removal by regulating protein phosphatase activities 47 , for example by phosphorylating B56 and activating PP2A-B56δ in human brain 48 Remarkably, both Arpp19 sites important for the control of meiosis resumption, S109 and S67, are dephosphorylated by a unique phosphatase, PP2A-B55δ. The function of Arpp19 phosphorylation at S67 in converting this protein into a PP2A-B55δ inhibitor is well documented, whereas the action of S109 phosphorylation of Arpp19 in ensuring the prophase arrest remains unknown. It is tempting to speculate that, by mirroring the function of S67-phosphorylated Arpp19, S109-phosphorylated Arpp19 regulates one of its regulatory kinases or phosphatase. Such a dual function has been described for two Arpp19-related proteins, DARPP-32 and Arpp16. Depending on its phosphorylation by PKA or by Cdk5 at two distinct sites, DARPP-32 acts as an inhibitor of either PP1 or PKA 51, 52 . Arpp16, exclusively expressed in the brain, and Arpp19, ubiquitously expressed, are alternatively spliced variants of the same gene 53, 54 . Like Arpp19, Arpp16 is phosphorylated by Gwl at S46 and by PKA at S88 53, 55 . As reported for Arpp19, Arpp16 is converted into a strong inhibitor of specific PP2A isoforms when phosphorylated by Gwl 55 . Interestingly, the PKA phosphorylated form of Arpp16 at S88 makes PP2A non-inhibitable 56 
and, in contrast to
Arpp19, phosphorylation of Arpp16 at S88 and S46 is mutually antagonistic 22, 56 . These findings raise the question of whether Arpp19 is a dual-function protein, like DARPP-32 or Arpp16. Although our preliminary attempts failed to show that S109-phosphorylated Arpp19 interacts with PP2A and regulates its activity, this hypothesis deserves deeper investigation.
Another possibility is that Arpp19 behaves as a PP1 inhibitor when phosphorylated by PKA, similarly to DARPP-32. In response to progesterone, S109 dephosphorylation of Arpp19 by PP2A-B55δ would activate PP1, an event that positively regulates entry into cell division 33, 57 .
Our results highlight how the reciprocal regulation of PP2A-B55δ and Arpp19 orchestrates the timing of the first meiotic division in Xenopus oocytes in a 3-step process ( Fig. 9 ). First, S109-phosphorylated Arpp19 and PP2A-B55δ secure the prophase arrest: PP2A-B55δ prevents any protein phosphorylation that could lead to unscheduled Cdk1 activation, while the action of S109-phosphorylated Arpp19 is not yet known. Second, progesterone triggers PKA inhibition while PP2A-B55δ stays active. As a consequence, Arpp19 is dephosphorylated at S109 and launches a several hours signaling pathway that ends with Cdk1 activation. Keeping PP2A-B55δ active prevents premature activation of Cdk1 and thus allows sufficient time for the signaling pathway, especially the translation of new proteins required for meiotic divisions. The third step is a switch conversion, relying on a threshold of a few active Cdk1 molecules. These activate Gwl, which in turn phosphorylates Arpp19 at S67 and inhibits PP2A-B55δ, setting up the bistable switches that govern irreversible Mphase entry 20, 58 . Since PP2A-B55δ is inhibited, Arpp19 can be rephosphorylated at S109.
Indeed, this is achieved by a kinase distinct from PKA and depending on Cdk1 activity 3 . The role of this new S109 phosphate, if any, is unknown. Hence, we discovered that a double function of PP2A-B55δ and its substrate, Arpp19, governs oocyte meiosis resumption, opening new avenues in the control of oocyte meiosis, but more widely in the control of cell cycle progression and its dysfunction in human pathologies related to fertility and cancer.
METHODS
Materials
Xenopus laevis adult females (Centre de Ressources Biologiques Xenopes, CNRS, France) were bred and maintained under laboratory conditions (Animal Facility Agreement: #A75-05-25). All reagents, unless otherwise specified, were from Sigma. Okadaic acid (OA) and magnetic GSH-beads were purchased from EnzoLifeSciences and Promega. Uno Q-25 was purchased from Bio-Rad, Mono Q 4.6/100PE, Phenyl-Superose HR5/5 and Superose 12 HR10/30 were from GE Healthcare.
Xenopus Oocyte handling
Full-grown prophase oocytes were obtained from unprimed Xenopus laevis females as described 59 . Oocytes were microinjected with OA (2 µM) or His-K71M-Gwl mRNA (150 µg) or the following recombinant proteins: Cter-GST-Arpp19 (125 ng, 250 ng or 500 ng), S109A-tpS67-Arpp19 (250 ng), p21 Cip1 (35 ng) or PKI (75 ng) in 50 nl final volume per oocyte. 2 µM progesterone was added to the external medium. Each in vivo experimental condition was applied to groups of 15 to 30 oocytes. Oocytes were referred to as GVBD when the first pigment rearrangement was detected at the animal pole.
Western blots
Oocytes were homogenized at 4°C in 10 volumes of Extraction Buffer (80 mM βglycerophosphate pH 7.3, 20 mM EGTA, 15 mM MgCl 2 ) and centrifuged at 15,000 g for 10 min at 4°C. For all proteins except endogenous Arpp19, an equivalent of 0.6 oocyte was subjected to SDS (12%, 10% or 8%) gel electrophoresis 60 and then transferred onto nitrocellulose as described 61 . To visualize endogenous Arpp19 protein, an equivalent of 1.2 oocytes was loaded on 15.5% Tris-Tricine gels 62 . The antibodies directed against the following proteins were used: Arpp19 63 (1:1000, gift of Dr Angus Nairn, Yale University, USA), S109-phosphorylated Arpp19 3 (1:500), S67-phosphorylated Arpp19 19 
Oocyte extracts, PP2A depletion and ammonium sulfate precipitation
Oocyte were homogenized in 5 volumes of Purification Buffer (PB: 80 mM β-Glycerophosphate pH 7.4, 10 mM EDTA, 30 mM NaCl, 3 mM DTT) and centrifuged at 15,000 g for 10 min at 4°C. Extracts were then supplemented or not with OA for 0.5h at 18°C and then with recombinant PKI at 0.15 mg/ml final concentration. For PP2A depletion, oocyte extracts were incubated twice for 30 min at 30°C with either 50 µl of Microcystin-Sepharose beads (Upstate) or 20 µl of magnetic GSH-beads, previously coupled or not to 2.5 µg of S67thiophosphorylated GST-Arpp19. Supernatants were then used for further analysis after removal of the beads. For ammonium sulfate precipitation, proteins of extracts from 100 oocytes were precipitated by salting out using ammonium sulfate, successively 20%, 40% and 60% as described 65 . Ammonium sulfate pellets were resuspended in 1 ml of PB for western blotting as well as S109-phosphatase and PKA assays.
Cloning and recombinant protein purification
Plasmids encoding either GST-tagged wild-type Arpp19 3 , GST-S109A-mutated Arpp19 3 , GST-p21 Cip1 29 , Histidine-tagged PKA catalytic subunit (a gift from Susan Taylor, Addgene plasmid #14921) and PKI 3 were previously described. The cDNA encoding the Cter-Arpp19 (amino-acids 68-117 of Arpp19) was cloned by PCR into a pGEX-6P-1 vector. Recombinant proteins were produced in E. coli by autoinduction 66 . Wild-type, mutated and truncated GST-Arpp19 proteins, GST-p21 Cip1 , His-PKA catalytic subunit and PKI were purified as described in 3, 29, 67 , dialyzed overnight against Phosphate Buffered Saline (PBS: 4.3 mM KH 2 PO 4 , 1.4 mM Na 2 HPO 4 pH 7.4, 13.7 mM NaCl, 2.7 mM KCl) and stored at -80°C.
In vitro phosphorylation of Arpp19 and GST pull-down
His-K71M-Gwl was obtained as described 19 . In vitro phosphorylation by PKA or thiophosphorylation by Gwl of recombinant GST-Arpp19 were respectively described in 22 and 19 . The double S109-S67 phosphorylated form of GST-Arpp19 was obtained by coupling 10 µg of recombinant GST-Arpp19 protein to 10 µl GSH-sepharose beads. After washing in PBS, beads were incubated for 3h at 30°C with 100 µl of metaphase II oocyte extracts supplemented with 2 mM ATP. The beads were then isolated, washed in PBS and used in prophase extracts to monitor S109 and S67 phosphatase activities. For GST pull down, GST-Arpp19 proteins were recovered from oocyte lysates as described previously 19 .
S109-phosphatase and PKA assays
1 µg of either pS109-GST-Arpp19 or GST-Arpp19, respectively used as substrates for S109-phosphatase or PKA, was coupled to 20 µl of magnetic GSH-beads for 0.5h at 18°C. After washing in PBS, GSH-beads coupled to Arpp19 proteins were incubated for 3h at 30°C with either 20 µl of oocyte extracts or 40 µl ammonium sulfate precipitates or 100 µl fractions from chromatography columns, supplemented with 2 mM ATP and 200 mM MgCl 2 . pS109-GST-Arpp19 or GST-Arpp19 coupled to beads were then isolated and western blotted using antibodies directed against S109-phosphorylated Arpp19 and GST. S109 phosphorylation level of Arpp19 was further quantified and normalized on total GST using Image J software.
Biochemical isolation of S109-phosphatase 20,000 prophase oocytes were homogenized at 4°C in 5 volumes of PB and successively centrifuged at 4°C at 300g for 5min, at 1,100g for 20min, at 15,000g for 20 min and at 100,000g for 2h (rotor TFT-45). The supernatant was then incubated with recombinant PKI at 0.15 mg/ml final concentration for 0.5h at 30°C and then loaded on a Uno Q-25 column previously equilibrated in PB. Proteins were eluted with a linear gradient of 0 to 1 M NaCl.
The flow through containing S109-phosphatase activity was loaded on a Mono 
LC-MS/MS data acquisition and processing
Proteins were incubated overnight at 37°C with 20 µl of 25 mM NH 4 HCO 3 containing sequencing-grade trypsin (12.5µg/ml, Promega) at 37°C. The resulting peptides were desalted using ZipTip µ-C18 Pipette Tips (Millipore) and analyzed in technical triplicates or individually by a Q-Exactive Plus coupled to a Nano-LC Proxeon 1000 equipped with an easy spray ion source (all from Thermo Scientific). Peptides were separated by chromatography with the following parameters: Acclaim PepMap100 C18 pre-column (2cm, 75µm i.d., 3µm, 
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FIGURE LEGENDS
Figure 1 I S109-phosphatase is OA-sensitive and counterbalanced by PKA in prophase oocytes.
(A-B) Extracts from prophase oocytes were supplemented or not with ATP and further incubated or not with PKI. Extracts were then incubated with either pS109-GST-Arpp19 (A) or GST-Arpp19 (B). S109 phosphorylation of GST-Arpp19 (pS109) and total GST-Arpp19 ( gst Arpp19) were western blotted using respectively phospho-S109-Arpp19 and GST antibodies. "S": starting substrates. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of S in (A), and to the phosphorylation level of GST-Arpp19 in the presence of ATP and without PKI in (B). (C) Extracts from prophase oocytes were supplemented or not with PKI and further incubated with pS109-GST-Arpp19, in the presence or in the absence of 1 µM or 10 µM OA. S109 phosphorylation of GST-Arpp19 (pS109) and total GST-Arpp19 ( gst Arpp19) were western blotted using respectively phospho-S109-Arpp19 and GST antibodies. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of GST-Arpp19 without PKI and OA. (D) Cter-GST-Arpp19 ( gst Cter) was injected into prophase (Pro) oocytes. 16h later, oocytes were stimulated either with progesterone (Pg) or by injecting either PKI or OA. Oocytes were collected at the indicated times after stimulation, and Cter-GST-Arpp19 was isolated by pull-down. S109 phosphorylation of Cter-GST-Arpp19 (pS109) and total Cter-GST-Arpp19 ( gst Cter) were western blotted using respectively phospho-S109-Arpp19 and GST antibodies. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of Cter-GST-Arpp19 in prophase oocytes. were western blotted using respectively phospho-S109-Arpp19 and GST antibodies. "S": starting pS109-GST-Arpp19 substrate. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of S. (C) PKA activity was assayed using as substrate GST-Arpp19. S109 phosphorylation of GST-Arpp19 (pS109) and total GST-Arpp19 ( gst Arpp19) were western blotted using respectively phospho-S109-Arpp19 and GST antibodies. "S": starting GST-Arpp19 substrate. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of GST-Arpp19 in the 60% precipitate without PKI. (D) Western blot analysis of AS precipitates using specific antibodies directed against catalytic subunits of PP1, PP2A (PP2A-C), PP4, PP5, PP6, PKA, and against PP2A scaffold subunit A (PP2A-A) and PKI.
Figure 3 I Biochemical isolation of S109-phosphatase from prophase extracts -Analysis of the output fractions of Uno Q and Mono Q columns.
PKI-supplemented extracts from prophase oocytes were fractionated by 2 successive steps of chromatography: Uno Q (A) and Mono Q (B). S109-phosphatase activity was assayed in each fraction using pS109-GST-Arpp19 as a substrate. S109 phosphorylation of GST-Arpp19 (pS109) and total GST-Arpp19 ( gst Arpp19) were western blotted using respectively phospho-S109-Arpp19 and GST antibodies. Fractions were western blotted with antibodies against the catalytic subunits of PP1, PP2A (PP2A-C), PP4, PP5 and PP6, PP2A scaffold subunit A (PP2A-A) and PP2A regulatory subunits B55δ and B56ε. *: non-specific protein recognized by the anti-B56ε antibody. "S": starting pS109-GST-Arpp19 substrate. "C": control extracts before PKI addition. "I": input sample supplemented with PKI and loaded on the column. "FT": flow-through. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of S. (A) Uno Q. FT and elution profile (fractions 1 to 3) of S109-phosphatase activity after Uno Q column and western blot analysis of fractions 1 to 6 of FT. (B) Mono Q. Fractions 2 to 5 of the Uno Q column FT (see A) were pooled and loaded on the column. Elution profile of S109-phosphatase activity after Mono Q column and western blot analysis of fractions 1 to 13. Continuation of experiment illustrated in Fig. 3 . "S": starting pS109-GST-Arpp19 substrate. "I": input sample loaded on the column. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of S. (A) Phenyl-Superose. Fraction 5 from the Mono Q column (see Fig. 3B ) was loaded on the column. Elution profile of S109phosphatase activity after Phenyl-Superose column and western blot analysis of fractions 3 to 15 with antibodies directed against catalytic subunits of PP2A (PP2A-C) and PP4, PP2A scaffold subunit A (PP2A-A) and PP2A regulatory subunit B55δ. (B) Superose 12. Fraction 11 from the Phenyl-Superose column (see A) was loaded on the column. Elution profile of S109-phosphatase activity after Superose 12 column and western blot analysis of fractions 2 to 13 with antibodies directed against PP2A scaffold subunit (PP2A-A), PP2A catalytic subunit (PP2A-C) and PP2A regulatory subunit B55δ. Continuation of experiment illustrated in Fig. 3 . "S": starting pS109-GST-Arpp19 substrate. "I": input sample loaded on the column. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of S. (A) Phenyl-Superose. Fractions 7 and 8 from the Mono Q column (see Fig. 3B ) were pooled and loaded on the column. Elution profile of S109-phosphatase activity after Phenyl-Superose column and western blot analysis of fractions 1 to 14 with antibodies directed against the catalytic subunits of PP1, PP2A (PP2A-C), PP4, PP5 and PP6, PP2A scaffold subunit (PP2A-A) and PP2A regulatory subunits B55δ and B56ε. (B) Superose 12. Fraction 10 and 11 from the Phenyl-Superose column (see A) were pooled and loaded on the column. Elution profile of S109-phosphatase activity after Superose 12 column and western blot analysis of fractions 3 to 14 with antibodies directed against the catalytic subunits of PP2A (PP2A-C) and PP5, PP2A scaffold subunit (PP2A-A) and PP2A regulatory subunits B55δ and B56ε. *non-specific protein recognized by the anti-PP5 antibody. (A-B) Prophase extracts were supplemented or not with PKI and further incubated with Arpp19 phosphorylated at both S109 and S67, pS67-pS109-GST-Arpp19, in the presence or in the absence of either 1 µM or 10 µM OA. Total GST-Arpp19 ( gst Arpp19) was western blotted with the anti-GST antibody. The phosphorylation of GST-Arpp19 at S109 (A) and at S67 (B) was visualized by western blot with antibodies directed against S109-phosphorylated Arpp19 (pS109) or S67-phosphorylated Arpp19 (pS67). "S": starting pS67-pS109-GST-Arpp19 substrate. (C) Prophase extracts were incubated twice with either microcystin beads (µCys), GSH-beads (GSH) or GST-Arpp19 thiophosphorylated at S67 and bound to GSHbeads (tpS67). After separation, the supernatants (SPN) and the beads resulting from the two incubation rounds were analyzed by western blot with antibodies directed against PP2A scaffold subunit (PP2A-A), PP2A catalytic subunit (PP2A-C) and PP2A regulatory subunit B55δ. "I": prophase extracts before depletion. (D) Supernatants of (C) were supplemented or not with PKI. S109-phosphatase activity was assayed using pS109-GST-Arpp19. After incubation, S109 phosphorylation of GST-Arpp19 (pS109) and total GST-Arpp19 ( gst Arpp19) were western blotted using respectively phospho-S109-Arpp19 (pS109) and GST antibodies. "S": starting pS109-GST-Arpp19 substrate. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to the phosphorylation level of S. (A) Prophase oocytes were injected or not with GST-Arpp19 thiophosphorylated at S67 and where S109 was mutated into A109 (S109A-tpS67-Arpp19) and then stimulated or not with progesterone (Pg). GVBD was scored as a function of time. (B) Same experiment as (A). Oocytes were collected in prophase (Pro) or at the indicated times after Pg addition and western blotted for S109-phosphorylated endogenous Arpp19 (pS109), total endogenous Arpp19, phosphorylated MAPK (pMAPK) and total MAPK. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to Arpp19 phosphorylation level in prophase oocytes. (A) Prophase oocytes (Pro) were injected or not with p21 Cip1 (Cip) and then stimulated with progesterone (Pg). GVBD occurred at 200 min in control oocytes and was prevented by Cip injection. Oocytes were collected at the indicated times after Pg addition and western blotted with antibodies against S109-phosphorylated Arpp19 (pS109), total Arpp19, phosphorylated MAPK (pMAPK) and total MAPK. S109 phosphorylation quantification: an arbitrary unit (a.u.) of 1 was attributed to Arpp19 phosphorylation level in prophase oocytes. (B) Prophase oocytes (Pro) were stimulated with progesterone (Pg). GVBD occurred at 150 min in control Prophase arrest (left box): both PP2A-B55δ and PKA are active, resulting in Arpp19 phosphorylation at S109. S109-phosphorylated Arpp19 locks the oocyte in prophase by an unknown mechanism, PKA contributes to this arrest through Arpp19 phosphorylation and possibly other substrates, PP2A-B55δ prevents Cdk1 activation. Transduction pathway (middle box): in response to progesterone, PKA is inhibited while PP2A-B55δ stays active, allowing Arpp19 dephosphorylation. Dephosphorylated Arpp19, possibly together with other dephosphorylated PKA substrates, launches a several hours long transduction pathway. Active PP2A-B55δ prevents Cdk1 activation, generating the time window necessary to set up the cascade of molecular events required for Cdk1 activation. M-phase entry (right box): Gwl is activated by a Cdk1 activity threshold and phosphorylates Arpp19 at S67 Hence, PP2A-B55δ is inhibited and Cdk1 fully activated. This hysteretic switch triggers M-phase entry.
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Active Inactive Active Supplementary Fig. 3 . Proteins present in the fractions with active S109-phosphatase after the Mono Q column (Q5, Q6 and Q7-8 -a pool of 7 and 8-), after the Phenyl-Superose column (PS11 from Q5, PS11 from Q6 and PS10-11 from Q7-8) and after Superose 12 column (S8 and S9 from Q5>PS11, S8 and S9 from Q6>PS11, S10 and S11 from Q7-8>PS10-11) were identified by LC-MS/MS analysis. The table lists proteins carrying a phosphatase enzymatic activity and their regulators. PP1-R: PP1 regulator.
